InforCapital

Corporate Venture Capital Firms in New York

3 investors found

Browse 3 Corporate Venture Capital Firms in New York. Discover top investors, their portfolios, AUM, and investment focus on InforCapital.

Lam Capital

Lam Capital

InvestorCanada

Lam Capital is the corporate venture capital investment arm of Lam Research Corporation, a global leader in wafer fabrication equipment and semiconductor manufacturing solutions. The firm invests in innovative companies addressing today's most challenging, high-impact problems across the semiconductor ecosystem, artificial intelligence, and industrial automation sectors. By combining financial investment with operational expertise and access to Lam Research's extensive technology network and supply chain infrastructure, Lam Capital serves as a strategic partner that goes beyond traditional venture funding to accelerate startup growth and commercialization.The firm's investment strategy is uniquely positioned at the intersection of corporate strategy and venture capital, focusing on companies that extend Lam Research's core technologies into new markets and synergistic technologies that solve complex challenges across multiple disciplines. Lam Capital invests across all stages from seed through early Series B, with a particular emphasis on hardware-related startups in semiconductor equipment, digital manufacturing, and related industries. The firm has made 18 investments as of April 2025, with a track record of 3 portfolio exits, including the notable exit of Reno Sub-Systems in March 2022.Beyond capital deployment, Lam Capital provides substantial value-add services including technical expertise from Lam Research's diverse pool of technology experts, operational guidance on scaling to high-volume manufacturing, potential customer relationships, and co-development opportunities. The firm's strategic approach integrates financial rigor with close collaboration with Lam Research's internal business units to maximize startup success and ensure strategic alignment that improves the likelihood of successful collaboration, integration, and eventual commercial deployment of portfolio company technologies.

Pfizer Ventures

Pfizer Ventures

InvestorUnited States1.0B AUM

Pfizer Ventures is the venture capital arm of Pfizer Inc., one of the world’s leading biopharmaceutical companies. Established to identify and invest in early-stage companies that align with Pfizer’s long-term strategy, Pfizer Ventures focuses on accelerating innovation in areas such as drug discovery, therapeutics, diagnostics, and healthcare technologies. The firm manages a dedicated investment portfolio, supporting biotech startups that are developing groundbreaking science and technologies across oncology, immunology, neuroscience, rare diseases, and digital health. Pfizer Ventures offers more than just capital; it brings deep scientific expertise, commercial insight, and access to Pfizer’s global network of R&D and business leaders. With an active presence in North America, Europe, and selected international markets, Pfizer Ventures seeks to foster partnerships that not only yield financial returns but also contribute to Pfizer’s overarching goal of delivering breakthroughs that change patients’ lives. The team operates with a collaborative, long-term mindset that supports companies from early development through commercialization.

Vine Ventures

Vine Ventures

InvestorUnited States243M AUM

Vine Ventures is a mission-driven venture capital firm that backs early-stage technology startups with a strong emphasis on founder support and long-term value creation. The firm is known for its hands-on approach, offering strategic guidance, operational expertise, and access to an influential network of partners, operators, and advisors.With a focus on fintech, SaaS, and consumer-facing technologies, Vine Ventures seeks out bold entrepreneurs building transformative solutions. It prioritizes companies that demonstrate clear paths to scalable impact and sustainable growth, particularly those serving traditionally underserved markets or innovating in legacy industries.Vine Ventures also actively supports Latin American startups and founders, reflecting its commitment to bridging U.S. and Latin America innovation ecosystems. With a diverse and dynamic portfolio, the firm is committed to fostering equitable access to capital and empowering the next generation of technology leaders.

You reached the end.

Understanding Corporate Venture Capital Firms in New York

Corporate venture capital (CVC) firms have become increasingly influential in the investment landscape, particularly in New York. These entities, backed by large corporations, focus on strategic investments that align with their parent companies' goals. The curated investor directory in New York highlights three prominent players in this category, showcasing their unique approaches and value propositions.

Investment Strategy and Focus

Strategic Alignment with Parent Companies

CVC firms typically align their investment strategies with the strategic interests of their parent corporations. This alignment often involves investing in startups and emerging companies that can complement or enhance the parent company's existing operations. By doing so, CVC firms not only seek financial returns but also aim to foster innovation and gain competitive advantages in their respective industries.

Diverse Industry Focus

Corporate venture capital firms in New York are known for their diverse industry focus. These firms often target sectors such as technology, healthcare, and finance, reflecting the broader industry interests of their parent corporations. This diversity allows them to tap into a wide range of opportunities and leverage their expertise to support portfolio companies effectively.

Geographic Presence and Network

New York as a Strategic Hub

New York serves as a strategic hub for corporate venture capital firms due to its vibrant business ecosystem and access to a diverse talent pool. The city's dynamic environment provides CVC firms with ample opportunities to identify promising startups and engage with innovative entrepreneurs. Additionally, New York's proximity to major financial centers enhances the networking potential for these investors, allowing them to form valuable connections with key stakeholders.

Global Reach and Influence

While based in New York, corporate venture capital firms often have a global reach. They leverage their parent companies' international presence and resources to identify and invest in opportunities beyond local borders. This global perspective enables CVC firms to capitalize on emerging trends and technologies worldwide, further enhancing their strategic value.

Importance for Limited Partners and Deal Professionals

Access to Strategic Partnerships

For limited partners (LPs) and deal professionals, engaging with corporate venture capital firms offers access to strategic partnerships and industry insights. CVC firms provide a unique vantage point, combining financial acumen with strategic foresight. This blend is particularly appealing to LPs seeking to diversify their investment portfolios and align with industry leaders.

Enhanced Deal Flow and Innovation

Corporate venture capital firms contribute to an enhanced deal flow by actively scouting for innovative startups and emerging technologies. Their strategic focus and industry expertise allow them to identify high-potential opportunities and facilitate meaningful collaborations between startups and their parent companies. This approach not only fosters innovation but also creates value for all parties involved.

In conclusion, corporate venture capital firms in New York play a pivotal role in shaping the investment landscape. Their strategic alignment with parent corporations, diverse industry focus, and global reach make them valuable partners for limited partners and deal professionals. As the curated investor directory highlights, these firms are well-positioned to drive innovation and create opportunities in New York and beyond.

Browse all investor directories →